Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
JMIR Research Protocols|April 5, 2024
Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Hazardous Alcohol Use Among Sexual Minority Cisgender Men and Transgender Individuals: Protocol for a Randomized Controlled TrialCarolyn Lauckner, Bryce Puesta Takenaka, Fidelis Sesenu, et al.Viruses|March 28, 2026
Wastewater Surveillance for SARS-CoV-2 in Rural Kentucky, 2021-2023James W Keck, Reuben Adatorwovor, Ann Noble, et al.Journal of Neuroimmunology|November 6, 2024
Influence of cocaine use reduction on markers of immune functionWilliam W Stoops, Thomas P Shellenberg, Sean D Regnier, et al.Clinical, Cosmetic and Investigational Dermatology|June 23, 2022
A CASE REPORT of Lichen Nitidus on the Penis: Tiny but Annoying EruptionsJingying Wang, Yinghao Pan, Guangmin Wei, et al.Emerging Infectious Diseases|February 26, 2024
Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021-2022James W Keck, Reuben Adatorwovor, Matthew Liversedge, et al.Drug and Alcohol Dependence|March 15, 2025
A single-blind, randomized, controlled contingency management trial on physiological indices and biomarkers of cardiovascular health in people with cocaine use disorderWilliam W Stoops, Thomas P Shellenberg, Sean D Regnier, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|March 15, 2015
Association between early airway damage-associated molecular patterns and subsequent bacterial infection in patients with inhalational and burn injuryRobert Maile, Samuel Jones, Yinghao Pan, et al.Science Bulletin|January 19, 2023
Genomewide decoupling of H2AK119ub1 and H3K27me3 in early mouse developmentYezhang Zhu, Jiali Yu, Yan Rong, et al.Cell Reports|December 7, 2025
Nuclear exosome targeting complex safeguards hematopoietic stem cell self-renewal and genomic integrity through resolving R loopsYinghao Pan, Hongna Zuo, Xianjin Yan, et al.Respiratory Research|July 25, 2016
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammationCharity G Duran, Allison J Burbank, Katherine H Mills, et al.Pageof 7